Anti‐HTLV‐III testing of blood donors

reproducibility and confirmability of commercial test kits

P. V. Holland, C. A. Richards, J. R. Teghtmeyer, C. M. Douville, J. R. Carlson, Steven Heye Hinrichs, N. C. Pedersen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Since 2% of the cases of Acquired Immune Deficiency Syndrome (AIDS) have been attributed to transfusions of blood and blood products, licensed tests to detect antibody to the human T‐lymphotropic virus type III (anti‐HTLV‐III) have been put into practice to reduce the risk of transfusion associated AIDS. Two commercial ELISA kits (Abbott and ENI) were used to test for anti‐HTLV‐III in 100 coded samples from individuals with AIDS, at high risk for AIDS, or with low risk for AIDS and in 1280 unlinked blood donor serums. From the 100 coded samples, both Abbott and ENI tests identified 51 of 52 coded samples with anti‐ HTLV‐III which were confirmable with Western blot analysis. Initial testing of the donor serums by Abbott's test revealed 20 reactives, of which 5 were repeatably reactive; initial testing by ENI's test revealed 25 reactives, of which 14 were repeatably reactive. However, only 3 donor serums were repeatably reactive by both test kits, out of 17 repeatable reactive by either, and no ELISA positive samples were confirmed by Western blot or IFA. Before a blood donor is notified of “anti‐HTLV‐III reactivity”, tests demonstrating this should be both reproducible and confirmable by at least one additional test. 1985 AABB

Original languageEnglish (US)
Pages (from-to)395-397
Number of pages3
JournalTransfusion
Volume25
Issue number4
DOIs
StatePublished - Jan 1 1985

Fingerprint

Blood Donors
Acquired Immunodeficiency Syndrome
Viruses
Antibodies
Western Blotting
Serum
Enzyme-Linked Immunosorbent Assay
Tissue Donors
Blood Transfusion

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology

Cite this

Holland, P. V., Richards, C. A., Teghtmeyer, J. R., Douville, C. M., Carlson, J. R., Hinrichs, S. H., & Pedersen, N. C. (1985). Anti‐HTLV‐III testing of blood donors: reproducibility and confirmability of commercial test kits. Transfusion, 25(4), 395-397. https://doi.org/10.1046/j.1537-2995.1985.25485273826.x

Anti‐HTLV‐III testing of blood donors : reproducibility and confirmability of commercial test kits. / Holland, P. V.; Richards, C. A.; Teghtmeyer, J. R.; Douville, C. M.; Carlson, J. R.; Hinrichs, Steven Heye; Pedersen, N. C.

In: Transfusion, Vol. 25, No. 4, 01.01.1985, p. 395-397.

Research output: Contribution to journalArticle

Holland, PV, Richards, CA, Teghtmeyer, JR, Douville, CM, Carlson, JR, Hinrichs, SH & Pedersen, NC 1985, 'Anti‐HTLV‐III testing of blood donors: reproducibility and confirmability of commercial test kits', Transfusion, vol. 25, no. 4, pp. 395-397. https://doi.org/10.1046/j.1537-2995.1985.25485273826.x
Holland, P. V. ; Richards, C. A. ; Teghtmeyer, J. R. ; Douville, C. M. ; Carlson, J. R. ; Hinrichs, Steven Heye ; Pedersen, N. C. / Anti‐HTLV‐III testing of blood donors : reproducibility and confirmability of commercial test kits. In: Transfusion. 1985 ; Vol. 25, No. 4. pp. 395-397.
@article{c7d7ad4dc50847fca53e0b3ad79bb58a,
title = "Anti‐HTLV‐III testing of blood donors: reproducibility and confirmability of commercial test kits",
abstract = "Since 2{\%} of the cases of Acquired Immune Deficiency Syndrome (AIDS) have been attributed to transfusions of blood and blood products, licensed tests to detect antibody to the human T‐lymphotropic virus type III (anti‐HTLV‐III) have been put into practice to reduce the risk of transfusion associated AIDS. Two commercial ELISA kits (Abbott and ENI) were used to test for anti‐HTLV‐III in 100 coded samples from individuals with AIDS, at high risk for AIDS, or with low risk for AIDS and in 1280 unlinked blood donor serums. From the 100 coded samples, both Abbott and ENI tests identified 51 of 52 coded samples with anti‐ HTLV‐III which were confirmable with Western blot analysis. Initial testing of the donor serums by Abbott's test revealed 20 reactives, of which 5 were repeatably reactive; initial testing by ENI's test revealed 25 reactives, of which 14 were repeatably reactive. However, only 3 donor serums were repeatably reactive by both test kits, out of 17 repeatable reactive by either, and no ELISA positive samples were confirmed by Western blot or IFA. Before a blood donor is notified of “anti‐HTLV‐III reactivity”, tests demonstrating this should be both reproducible and confirmable by at least one additional test. 1985 AABB",
author = "Holland, {P. V.} and Richards, {C. A.} and Teghtmeyer, {J. R.} and Douville, {C. M.} and Carlson, {J. R.} and Hinrichs, {Steven Heye} and Pedersen, {N. C.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1046/j.1537-2995.1985.25485273826.x",
language = "English (US)",
volume = "25",
pages = "395--397",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Anti‐HTLV‐III testing of blood donors

T2 - reproducibility and confirmability of commercial test kits

AU - Holland, P. V.

AU - Richards, C. A.

AU - Teghtmeyer, J. R.

AU - Douville, C. M.

AU - Carlson, J. R.

AU - Hinrichs, Steven Heye

AU - Pedersen, N. C.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Since 2% of the cases of Acquired Immune Deficiency Syndrome (AIDS) have been attributed to transfusions of blood and blood products, licensed tests to detect antibody to the human T‐lymphotropic virus type III (anti‐HTLV‐III) have been put into practice to reduce the risk of transfusion associated AIDS. Two commercial ELISA kits (Abbott and ENI) were used to test for anti‐HTLV‐III in 100 coded samples from individuals with AIDS, at high risk for AIDS, or with low risk for AIDS and in 1280 unlinked blood donor serums. From the 100 coded samples, both Abbott and ENI tests identified 51 of 52 coded samples with anti‐ HTLV‐III which were confirmable with Western blot analysis. Initial testing of the donor serums by Abbott's test revealed 20 reactives, of which 5 were repeatably reactive; initial testing by ENI's test revealed 25 reactives, of which 14 were repeatably reactive. However, only 3 donor serums were repeatably reactive by both test kits, out of 17 repeatable reactive by either, and no ELISA positive samples were confirmed by Western blot or IFA. Before a blood donor is notified of “anti‐HTLV‐III reactivity”, tests demonstrating this should be both reproducible and confirmable by at least one additional test. 1985 AABB

AB - Since 2% of the cases of Acquired Immune Deficiency Syndrome (AIDS) have been attributed to transfusions of blood and blood products, licensed tests to detect antibody to the human T‐lymphotropic virus type III (anti‐HTLV‐III) have been put into practice to reduce the risk of transfusion associated AIDS. Two commercial ELISA kits (Abbott and ENI) were used to test for anti‐HTLV‐III in 100 coded samples from individuals with AIDS, at high risk for AIDS, or with low risk for AIDS and in 1280 unlinked blood donor serums. From the 100 coded samples, both Abbott and ENI tests identified 51 of 52 coded samples with anti‐ HTLV‐III which were confirmable with Western blot analysis. Initial testing of the donor serums by Abbott's test revealed 20 reactives, of which 5 were repeatably reactive; initial testing by ENI's test revealed 25 reactives, of which 14 were repeatably reactive. However, only 3 donor serums were repeatably reactive by both test kits, out of 17 repeatable reactive by either, and no ELISA positive samples were confirmed by Western blot or IFA. Before a blood donor is notified of “anti‐HTLV‐III reactivity”, tests demonstrating this should be both reproducible and confirmable by at least one additional test. 1985 AABB

UR - http://www.scopus.com/inward/record.url?scp=0021968106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021968106&partnerID=8YFLogxK

U2 - 10.1046/j.1537-2995.1985.25485273826.x

DO - 10.1046/j.1537-2995.1985.25485273826.x

M3 - Article

VL - 25

SP - 395

EP - 397

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 4

ER -